Live updates: Supreme Court backs Trump in ballroom suit; House returns with shutdown bill on tap

The week in Washington opens with a flurry of consequential moves, from the judiciary to the battlefield to the budget. The Supreme Court’s 5-4 decision allowing the White House ballroom project to proceed may seem like a niche property dispute, but it underscores a broader trend: the current Court is often willing to narrow the doors of standing for outside groups challenging executive actions. For observers of executive power, this ruling is less about architecture and more about who gets to hold the presidency accountable in court. At the same time, President Trump’s announcement on prescription drug pricing continues a bipartisan-sounding theme of lowering costs, yet his "most favored nation" model has drawn sharp criticism from both pharma executives and some economists who argue it could stifle innovation or simply shift costs. The policy reflects a populist push against high drug prices, but the execution remains contentious. It’s a reminder that even when the president frames an issue as universally beneficial, the details often reveal deep partisan and policy rifts. The renewed U.S. strikes on Iran add another layer of urgency. While the administration frames these as defensive responses to threats, critics warn of escalation without a clear strategy. Combined with the looming House spending bill, the picture is one of a president aggressively using executive power on multiple fronts while Congress struggles to perform its most basic fiscal duty. The spending fight will test whether lawmakers can avoid a shutdown—a recurring crisis that voters increasingly view as a failure of governance. As the day unfolds, the common thread is the consolidation of decision-making in the executive branch, with the judiciary and Congress reacting rather than leading. For voters, the question is not whether these policies are popular in isolation, but whether the balance of power is shifting in ways that outlast any single administration. The Supreme Court’s standing ruling, the drug pricing gambit, and the Iran strikes all point to a presidency that is willing to test limits—and a system still trying to define those limits. For ongoing updates, see the original article at [The Hill](https://thehill.com/homenews/administration/6060538-live-updates-trump-iran-house-spending-cr/).